Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $2.41 Billion - $2.91 Billion
-14,577,136 Reduced 99.32%
99,440 $16.8 Million
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $64.9 Million - $85.8 Million
-428,841 Reduced 2.84%
14,676,576 $2.9 Billion
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $26.2 Million - $30.2 Million
-156,614 Reduced 1.03%
15,105,417 $2.63 Billion
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $27 Million - $31.2 Million
167,641 Added 1.11%
15,262,031 $2.63 Billion
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $355 Million - $428 Million
2,443,388 Added 19.31%
15,094,390 $2.51 Billion
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $442 Million - $531 Million
3,373,781 Added 36.37%
12,651,002 $1.85 Billion
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $313 Million - $386 Million
2,111,982 Added 29.48%
9,277,221 $1.38 Billion
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $290 Million - $372 Million
1,857,752 Added 35.0%
7,165,239 $1.23 Billion
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $901 Million - $1.16 Billion
4,964,646 Added 1448.09%
5,307,487 $1 Billion
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $97,426 - $124,256
503 Added 0.15%
342,841 $83.7 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $602,320 - $667,233
3,182 Added 0.94%
342,338 $66.5 Million
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $37.7 Million - $45.5 Million
-241,904 Reduced 41.63%
339,156 $63.2 Million
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $428 Million - $475 Million
-2,723,573 Reduced 82.42%
581,060 $96.2 Million
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $233,892 - $282,121
-1,706 Reduced 0.05%
3,304,633 $546 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $15.9 Million - $20.2 Million
141,679 Added 4.48%
3,306,339 $453 Million
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $293 Million - $459 Million
3,164,660 New
3,164,660 $372 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.